| Item Type | Name |
|
Academic Article
|
Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002.
|
|
Academic Article
|
Docetaxel followed by gemcitabine and irinotecan in solid tumors.
|
|
Concept
|
Survival Rate
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
Survival
|
|
Academic Article
|
EUS-guided fine needle aspiration with and without trucut biopsy of pancreatic masses.
|
|
Academic Article
|
Phase Ib study of drozitumab combined with first-line mFOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer.
|
|
Academic Article
|
Update on pancreatic cancer.
|
|
Academic Article
|
Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system.
|
|
Academic Article
|
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.
|
|
Academic Article
|
Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma.
|
|
Academic Article
|
Surgical outcomes of gastrointestinal sarcoma including gastrointestinal stromal tumors: a population-based examination.
|
|
Academic Article
|
Novel advances in pancreatic cancer treatment.
|
|
Academic Article
|
Treatment of relapsed small-cell lung cancer--a focus on the evolving role of topotecan.
|
|
Academic Article
|
Bortezomib with or without irinotecan in relapsed or refractory colorectal cancer: results from a randomized phase II study.
|
|
Academic Article
|
A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinoma.
|
|
Academic Article
|
Oxaliplatin and fixed-rate infusional gemcitabine in the second-line treatment of patients with metastatic colon cancer: final results of a Phase II trial prematurely closed as a result of poor accrual.
|
|
Academic Article
|
Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B.
|
|
Academic Article
|
Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy.
|
|
Academic Article
|
Role of combined-modality therapy in the management of locally advanced rectal cancer.
|
|
Academic Article
|
Irinotecan plus gemcitabine induces both radiographic and CA 19-9 tumor marker responses in patients with previously untreated advanced pancreatic cancer.
|
|
Academic Article
|
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902.
|
|
Academic Article
|
A phase 1 trial of E7974 administered on day 1 of a 21-day cycle in patients with advanced solid tumors.
|
|
Academic Article
|
Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma?
|
|
Academic Article
|
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer.
|
|
Academic Article
|
A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancer.
|
|
Academic Article
|
Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study.
|
|
Academic Article
|
Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC).
|
|
Academic Article
|
Radiation and chemotherapy for patients with stage III non-small cell lung cancer.
|
|
Academic Article
|
Advances in treatment of inoperable NSCLC: gemcitabine doublets--a promising alternative.
|
|
Academic Article
|
A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere.
|
|
Academic Article
|
Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment.
|
|
Academic Article
|
Preoperative docetaxel/cisplatin/5-fluorouracil chemotherapy in patients with locally advanced gastro-esophageal adenocarcinoma.
|
|
Academic Article
|
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.
|
|
Academic Article
|
Metastatic colorectal cancer: systemic treatment in the new millennium.
|
|
Academic Article
|
Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancer.
|
|
Academic Article
|
Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors.
|
|
Academic Article
|
Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institution.
|
|
Academic Article
|
Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer.
|
|
Academic Article
|
Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate.
|
|
Academic Article
|
Comparison of cancer care and outcomes between a public safety-net hospital and a private cancer center.
|